Overview

Use Of Fragmin In Hemodialysis

Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The study will determine if the Fragmin dose can be adjusted to suit the clinical needs of patients during dialysis.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Dalteparin
Heparin, Low-Molecular-Weight